Crossref
Anticancer agent 6-MITC at extremely low dosage can control seizures by stabilizing membrane excitability system in mutant EL mice
Epilepsy & Seizure · 2018
DOI: 10.3805/eands.10.44 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Seizure, 2018. Verfasst von Yoshiya L. Murashima und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Murashima, Y. L., Shinoda, S., & Fuke, Y. (2018). Anticancer agent 6-MITC at extremely low dosage can control seizures by stabilizing membrane excitability system in mutant EL mice. Epilepsy & Seizure. https://doi.org/10.3805/eands.10.44
Vancouver
Murashima YL, Shinoda S, Fuke Y. Anticancer agent 6-MITC at extremely low dosage can control seizures by stabilizing membrane excitability system in mutant EL mice. Epilepsy & Seizure. 2018. doi:10.3805/eands.10.44
BibTeX
@article{Murashima2018,
author = {Murashima, Yoshiya L. and Shinoda, Shoko and Fuke, Yoko},
title = {Anticancer agent 6-MITC at extremely low dosage can control seizures by stabilizing membrane excitability system in mutant EL mice},
journal = {Epilepsy & Seizure},
year = {2018},
doi = {10.3805/eands.10.44}
}
EUVIMED